MCID: RMS001
MIFTS: 41

Rem Sleep Behavior Disorder malady

Category: Mental diseases

Aliases & Classifications for Rem Sleep Behavior Disorder

About this section

Aliases & Descriptions for Rem Sleep Behavior Disorder:

Name: Rem Sleep Behavior Disorder 11 50 39 13 68
 
Rapid Eye Movement Sleep Behavior Disorder 11

Classifications:



External Ids:

Disease Ontology11 DOID:9091
ICD1030 G47.52
SNOMED-CT62 415238003
ICD9CM32 327.42
MeSH39 D020187

Summaries for Rem Sleep Behavior Disorder

About this section
Disease Ontology:11 A sleep disorder that involves abnormal behavior including the acting out of violent or dramatic dreams during the sleep phase with rapid eye movement.

MalaCards based summary: Rem Sleep Behavior Disorder, also known as rapid eye movement sleep behavior disorder, is related to machado-joseph disease and dementia. An important gene associated with Rem Sleep Behavior Disorder is SNCA (Synuclein Alpha), and among its related pathways are Alpha-synuclein signaling and Neurotransmitter Clearance In The Synaptic Cleft. Affiliated tissues include eye, brain and testes, and related mouse phenotypes are behavior/neurological and nervous system.

Wikipedia:71 Rapid eye movement sleep behavior disorder (RBD) is a sleep disorder (more specifically a parasomnia)... more...

Related Diseases for Rem Sleep Behavior Disorder

About this section

Diseases related to Rem Sleep Behavior Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 64)
idRelated DiseaseScoreTop Affiliating Genes
1machado-joseph disease11.5
2dementia10.5
3narcolepsy10.4
4sleep apnea10.3
5obstructive sleep apnea10.2
6synucleinopathy10.2
7ceroid lipofuscinosis, neuronal, 110.2LRRK2, SNCA
8lethal congenital contracture syndrome 810.2LRRK2, SNCA
9spink1-related hereditary pancreatitis10.2LRRK2, SNCA
10transient neonatal myasthenia gravis10.2LRRK2, SNCA
11thrombosis10.2LRRK2, SNCA
12multiple system atrophy10.2
13trichothiodystrophy 3, photosensitive10.2LRRK2, SNCA
14riedel's fibrosing thyroiditis10.2LRRK2, SNCA
15klippel-feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism10.2LRRK2, SNCA
16deafness, autosomal recessive 10110.1RPS27A, SNCA
17cystic echinococcosis10.1RPS27A, SNCA
18cyprus facial neuromusculoskeletal syndrome10.1RPS27A, SNCA
19pythiosis10.1ACHE, SNCA
20hemangioblastoma10.1HCRT, SNCA
21nephrogenic adenoma of the urethra10.1SLC6A3, SNCA
22sleep disorder10.1
23plekhm1-related autosomal recessive osteopetrosis10.1LRRK2, SNCA
24benign partial epilepsy with secondarily generalized seizures in infancy10.1LRRK2, SLC6A3, SNCA
25atrial septal defect 910.1HCRT, SNCA
26thyrotropin-releasing hormone deficiency10.1LRRK2, SLC6A3, SNCA
27cavernous hemangioma10.1LRRK2, SLC6A3, SNCA
28ovarian mucinous adenocarcinoma10.0ACHE, SLC6A3, SNCA
29mitochondrial dna depletion syndrome 310.0SLC6A3, SNCA
30hypoproteinemia, hypercatabolic10.0LRRK2, RPS27A, SNCA
31proteus syndrome, somatic10.0RPS27A, SLC6A3, SNCA
32squamous blepharitis10.0SNCA, TCOF1
33myopathy, distal, with early respiratory failure, autosomal dominant10.0HCRT, SLC6A3
34rheumatoid arthritis10.0
35arthritis10.0
36corticobasal degeneration10.0
37pure autonomic failure10.0
38autoimmune disease of urogenital tract10.0LRRK2, SNCA
39personality disorder10.0HCRT, SLC6A3, SNCA
40usher syndrome10.0HCRT, SLC6A3
41preeclampsia/eclampsia 59.9SLC17A5, SLC6A3, SNCA
42eumycotic mycetoma9.9ACHE, LRRK2, SLC6A3, SNCA
43substance-induced psychosis9.9ACHE, LRRK2, SLC6A3, SNCA
44autism 199.9LRRK2, RPS27A, SLC6A3, SNCA
45gallbladder adenoma9.9LRRK2, RPS27A, SLC6A3, SNCA
46hemochromatosis, type 2a9.9LRRK2, RPS27A, SLC6A3, SNCA
47cardiomyopathy, dilated, 1u9.9ACHE, LRRK2, RPS27A, SNCA
48alzheimer disease9.8
49obsessive-compulsive disorder9.8
50restless legs syndrome9.8

Graphical network of the top 20 diseases related to Rem Sleep Behavior Disorder:



Diseases related to rem sleep behavior disorder

Symptoms & Phenotypes for Rem Sleep Behavior Disorder

About this section

MGI Mouse Phenotypes related to Rem Sleep Behavior Disorder according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053868.5ACHE, HCRT, LRRK2, SLC17A5, SLC6A3, SNCA
2MP:00036316.9ACHE, HCRT, LRRK2, SLC17A5, SLC6A3, SNCA

Drugs & Therapeutics for Rem Sleep Behavior Disorder

About this section

Drugs for Rem Sleep Behavior Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 81)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Hydrocortisoneapproved, vet_approvedPhase 466750-23-75754, 657311
Synonyms:
(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione
(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione
11-Hydrocortisone
11-beta-Hydrocortisone
11-beta-Hydroxycortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b,17,21-Trihydroxyprogesterone
11b-Hydrocortisone
11b-Hydroxycortisone
11beta,17,21-Trihydroxyprogesterone
11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione
11beta-Hydrocortisone
11beta-Hydroxycortisone
11beta-hydrocortisone
11╬▓-hydrocortisone
17-Hydroxycorticosterone
17a-Hydroxycorticosterone
17alpha-Hydroxycorticosterone
2v95
4-Pregnen-11beta,17alpha,21-triol-3,20-dione
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
50-23-7
8056-08-4
80562-38-5
8063-42-1
AC-12902
AC1L1L2B
ACETASOL HC
ACETIC ACID W/ HYDROCORTISONE
AI3-25006
AKOS001582651
Acticort
Acticort (TN)
Aeroseb HC
Aeroseb-HC
Ala-Cort
Ala-Scalp
Alacort
Algicirtis
Alphaderm
Amberin
Anflam
Anti-inflammatory hormone
Anucort
Anucort-HC
Anusol HC
Anusol HC (TN)
Aquacort
Aquanil HC
B48448A1-24BA-47CA-8D9E-43E5BC949386
BPBio1_000544
BRD-K93568044-001-03-1
BSPBio_000494
Balneol-hc
Barseb HC
Basan-Corti
Beta-hc
Bio-0648
C00735
C21H30O5
CCRIS 5854
CHEBI:17650
CHEMBL389621
CID5754
COR-OTICIN
CPD000653523
CaldeCORT Spray
Cetacort
Chronocort
Clear aid
Cleiton
Cobadex
Colocort
Colocort (TN)
Compound F
Compound F (kendall)
Cor-Tar-Quin
Corhydron
Cort-Dome
Cort-Quin
Cortanal
Cortef
Cortef (TN)
Cortenema
Cortesal
Corticreme
Cortifair
Cortifan
Cortifoam
Cortiment
Cortisol
Cortisol alcohol
Cortisol, Hydrocortisone
Cortisolonum
Cortisporin
Cortisporin Otico
Cortispray
Cortizol
Cortolotion
Cortonema
Cortoxide
Cortril
Cremesone
Cremicort-H
Cutisol
Cyclodextrin-encapsulated hydrocortisone
D00088
DB00741
DB07886
Delacort
Derm-Aid
Dermacort
Dermaspray
Dermil
Dermocortal
Dermolate
Dihydrocostisone
Dioderm
Dome-cort
Domolene-HC
Drotic
DuoCort
EINECS 200-020-1
EU-0100594
Ef corlin
Efcorbin
Efcortelan
Efcortelin
Eldecort
Eldercort
Epicort
Epicortisol
Epiderm H
Esiderm H
Evacort
Ficortril
Fiocortril
Flexicort
Foille Insetti
Genacort
Genacort (lotion)
Glycort
Gyno-Cortisone
H 4001
H-Cort
H0135_SIGMA
H0396_SIGMA
H0888_SIGMA
H3160_SIGMA
H4001_SIGMA
H6909_SIGMA
HC
HC #1
 
HC #4
HC (HYDROCORTISONE)
HMS1569I16
HMS2090M04
HSDB 3339
HYDROCORTISONE AND ACETIC ACID
HYDROCORTISONE IN ABSORBASE
Heb Cort
Heb-Cort
Hi-cor
Hidalone
Hidro-Colisona
Hidrocortisona
Hidrocortisona [INN-Spanish]
Hycort
Hycortol
Hycortole
Hydracort
Hydrasson
Hydro-Adreson
Hydro-Colisona
Hydro-RX
Hydro-colisona
Hydrocort
Hydrocortal
Hydrocorticosterone
Hydrocortisone
Hydrocortisone (JP15/USP/INN)
Hydrocortisone Acetate
Hydrocortisone Base
Hydrocortisone Butyrate
Hydrocortisone Sodium Phosphate
Hydrocortisone Valerate
Hydrocortisone [INN:BAN:JAN]
Hydrocortisone alcohol
Hydrocortisone base
Hydrocortisone free alcohol
Hydrocortisone solution
Hydrocortisone-Water Soluble
Hydrocortisonum
Hydrocortisonum [INN-Latin]
Hydrocortistab
Hydrocortisyl
Hydrocortone
Hydroskin
Hydroxycortisone
Hysone
Hytisone
Hytone
Hytone (TN)
Hytone lotion
Idrocortisone
Idrocortisone [DCIT]
Incortin-H
Incortin-hydrogen
Kendall'S compound F
Kendall's compound F
Komed HC
Kyypakkaus
LMST02030001
LS-7439
Lacticare HC
Lacticare-HC
Lactisona
Lopac0_000594
Lubricort
MLS000069609
MLS001148103
MLS002207135
MLS002222189
Maintasone
Medicort
Meusicort
Mildison
Milliderm
MolPort-001-794-637
NCGC00022848-06
NCGC00022848-07
NCGC00022848-09
NCGC00022848-12
NCI60_000118
NSC 10483
NSC-10483
NSC10483
Neo-Cort-Dome
Neo-Cortef
Neosporin-H Ear
Nogenic HC
Nutracort
Nystaform-HC
ORLEX HC
Optef
Otalgine
Otic-Neo-Cort-Dome
Otobiotic
Otocort
Otosone-F
Pediotic Suspension
Penecort
Permicort
Polcort H
Preparation H Hydrocortisone Cream
Prepcort
Prestwick0_000447
Prestwick1_000447
Prestwick2_000447
Prestwick3_000447
Prestwick_265
Prevex HC
Proctocort
Proctofoam
Proctozone HC
Protocort
Racet
Rectasol-HC
Rectoid
Reichstein'S substance M
Reichstein's substance M
Remederm HC
S1696_Selleck
SAM002264617
SMP1_000156
SMR000059022
SMR000653523
SPBio_002433
Sanatison
Scalp-Cort
Scalpicin Capilar
Schericur
Scheroson F
Sigmacort
Signef
Stie-cort
Stiefcorcil
Synacort
Systral Hydrocort
Tarcortin
Texacort
Texacort lotion 25
Timocort
Topicort
Transderma H
Traumaide
UNII-WI4X0X7BPJ
UPCMLD-DP133
UPCMLD-DP133:001
Uniderm
Vioform-Hydrocortisone
VoSol HC
Vytone
Zenoxone
[3H]cortisol
component of Lubricort
component of Neo-Cort-Dome
component of Otalgine
hydrocortisone
2
BupropionapprovedPhase 432934841-39-9, 34911-55-2444
Synonyms:
( -)-2-(tert-Butylamino)-3'-chloropropiophenone
( -)-2-(tert-Butylamino)-3'-chlorpropiophenon
(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
.alpha.-(tert-Butylamino)-m-chloropropiophenone
1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one
2-(Tert-Butylamino)-3'-chloropropiophenone
2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one
34841-36-6 (hydrochloride)
34841-39-9
34911-55-2
AB00053756
AC-197
AC1L198Y
AMFEBUTAMONE HCl
Amfebutamon
Amfebutamona
Amfebutamona [INN-Spanish]
Amfebutamone
Amfebutamonum
Amfebutamonum [INN-Latin]
BPBio1_000042
BRD-A05186015-003-05-7
BRN 2101062
BSPBio_000038
BSPBio_002247
Bupropion (INN)
Bupropion (Old RN)
Bupropion (USAN)
Bupropion Hcl
Bupropion SR
Bupropion [INN:BAN]
Bupropion hydrocloride
C06860
CHEBI:3219
CHEMBL894
CID444
CPD000472526
D07591
DB01156
DivK1c_007050
Elont
 
HMS2051G10
HMS2089G14
Jsp006301
KBio1_001994
KBio2_002143
KBio2_004711
KBio2_007279
KBio3_001467
KBioGR_001168
KBioSS_002143
L000725
LS-122817
Lopac0_000166
MLS001424015
MolPort-003-845-432
NCGC00015122-06
NCGC00089751-02
NCI60_002714
NSC315851
Prestwick0_000249
Prestwick1_000249
Prestwick2_000249
Prestwick3_000249
SAM001246699
SMR000472526
SPBio_001817
SPBio_002257
SpecPlus_000954
Spectrum2_001659
Spectrum3_000644
Spectrum4_000614
Spectrum5_001406
Spectrum_001663
TL8002604
UNII-01ZG3TPX31
Wellbatrin
Wellbutrin
Wellbutrin SR
Wellbutrin XL
Zyban
alpha-(tert-butylamino)-m-chloropropiophenone
amfebutamonum
bupropion
3
CitalopramapprovedPhase 451259729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
4
DopamineapprovedPhase 4383651-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
5
Olanzapineapproved, investigationalPhase 4399132539-06-14585
Synonyms:
132539-06-1
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10 H -thieno[2,3- b ] [1,5]benzodiazepine
2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine
2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine
AC-665
AC1L1IHS
AKOS000282888
ALKS-7921
BIDD:GT0332
BIDD:PXR0138
Bio-0169
C07322
C076029
C17H20N4S
CHEBI:7735
CHEMBL715
CID4585
CPD000466345
D00454
DB00334
Eli Lilly brand of olanzapine
HMS2051H05
HMS2089M04
HMS2093I04
I06-0784
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H
InChI=1/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3
Jsp001969
KS-1090
L000455
L005958
LS-152313
LY 170053
LY-170052
 
LY-170053
Lanzac
Lilly brand of olanzapine
MLS000759457
MLS001165781
MLS001195646
MLS001424057
Midax
MolPort-002-885-845
MolPort-003-666-569
MolPort-005-977-341
NCGC00096077-01
NCGC00096077-03
NCGC00096077-04
Olansek
Olanzapin
Olanzapina
Olanzapine
Olanzapine (JAN/USAN/INN)
Olanzapine (OLA)
Olanzapine [USAN:INN]
Olanzapinum
S2493_Selleck
SAM001246652
SMR000466345
SPECTRUM1505024
STK634338
Symbyax
TL8000772
UNII-N7U69T4SZR
Zalasta
Zydis
Zyprexa
Zyprexa (TN)
Zyprexa Intramuscular
Zyprexa Velotab
Zyprexa Zydis
olanzapina
olanzapine
olanzapinum
6
ZiprasidoneapprovedPhase 4145146939-27-760854
Synonyms:
138982-67-9 (hydrochloride monohydrate)
146939-27-7
5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one
5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one
6-chloro-5-[2-[4-(7-thia-8-azabicyclo[4.3.0]nona-1,3,5,8-tetraen-9-yl)piperazin-1-yl]ethyl]-1,3-dihydroindol-2-one
AC1L1U27
Ambap122883-93-6
BIDD:GT0042
C07568
C21H21ClN4OS
CHEBI:10119
CHEMBL708
CID60854
CP 88059
CP 88059-01
CP-88,059
CP-88,059-01
CP-88,059-1
CP-88059-1
CPD000466328
D08687
DB00246
 
Geodon
Geodon Oral
I14-0766
L000659
LS-83744
MLS000759435
MolPort-003-850-885
SAM001246607
SMR000466328
TL8000889
UNII-6UKA5VEJ6X
Zeldox
Zipradon
Zipradon (TN)
Ziprasidona
Ziprasidone
Ziprasidone (INN)
Ziprasidone [INN:BAN]
Ziprasidone hydrochloride
Ziprasidone mesylate trihydrate
Ziprasidonum
ziprasidona
ziprasidonum
ziprazidone
7
MianserinapprovedPhase 45224219-97-44184
Synonyms:
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,F)pyrazino(1,2-a)azepine
1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine
2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine
21535-47-7 (mono-hydrochloride)
24219-97-4
AC-631
AC1L1HLP
BPBio1_000064
BPBio1_000331
BRD-A19661776-001-01-5
BRD-A19661776-003-05-2
BRN 0755346
BSPBio_000058
BSPBio_003511
Biomol-NT_000135
Bolvidon
C18H20N2
CHEBI:51137
CHEMBL6437
CID4184
D08216
DB06148
DivK1c_000844
EINECS 246-088-6
HMS2089A04
HSDB 7182
IDI1_000844
KBio1_000844
KBio2_002301
KBio2_004869
KBio2_007437
KBio3_003016
KBioGR_001820
KBioSS_002303
L000736
LS-61197
Lopac0_000744
 
Mianserin (INN)
Mianserin Monohydrochloride
Mianserin [INN:BAN]
Mianserina
Mianserina [INN-Spanish]
Mianserina [inn-spanish]
Mianserine
Mianserine [INN-French]
Mianserine [inn-french]
Mianserinum
Mianserinum [INN-Latin]
Mianserinum [inn-latin]
Mianseryna
Mianseryna [Polish]
Mianseryna [polish]
MolPort-003-849-215
NCGC00015656-09
NCGC00024926-03
NCGC00024926-04
NINDS_000844
Norval
Oprea1_703627
PDSP1_001532
PDSP2_001516
Prestwick0_000099
Prestwick1_000099
Prestwick2_000099
Prestwick3_000099
SPBio_000986
SPBio_001997
Spectrum2_001203
Spectrum3_001836
Spectrum4_001260
Spectrum5_001772
Spectrum_001810
Tolvan
Tolvon
Tolvon (TN)
mianserin
8
Histamineapproved, investigationalPhase 4105075614-87-8, 51-45-6774
Synonyms:
.beta.-Imidazolyl-4-ethylamine
1H-Imidazole-4-ethanamine
1H-Imidazole-5-ethanamine
1avn
1qft
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(1H-imidazol-4-yl)ethan-1-amine
2-(1H-imidazol-5-yl)ethanamine
2-(3H-Imidazol-4-yl)-ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-Imidazolyl)ethylamine
2-(4-imidazolyl)ethylamine
2-Imidazol-4-yl-Ethylamine
2-Imidazol-4-ylethylamine
2-[4-Imidazolyl]ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-Imidazoleethylamine
4-imidazoleethylamine
5-Imidazoleethylamine
5-imidazoleethylamine
51-45-6
53290_FLUKA
64422-25-9
924364-91-0
AC-13185
AC1L19ZT
AC1Q54BV
AC1Q54BW
AKOS000274386
ALBB-005968
BCBcMAP01_000250
BSPBio_001117
BSPBio_002124
Bio1_000487
Bio1_000976
Bio1_001465
Bio2_000389
Bio2_000869
C00388
CCRIS 6535
CHEBI:18295
CHEMBL90
CID774
D08040
DivK1c_000308
EINECS 200-100-6
Eramin
Ergamine
Ergotidine
F411C768-A159-4FC0-A195-291A08BB03AA
Free histamine
H7125_SIGMA
HMS1362G19
HMS1792G19
HMS1990G19
HSDB 3338
HSM
Histamine
Histamine (DCF)
Histamine Base
Histamine [USAN]
Histamine, Free Base
Histaminum
 
Histaminum (TN)
IDI1_000308
IDI1_002144
Imidazole-4-ethylamine
Istamina
Istamina [Italian]
KBio1_000308
KBio2_000457
KBio2_001325
KBio2_003025
KBio2_003893
KBio2_005593
KBio2_006461
KBio3_000853
KBio3_000854
KBio3_001344
KBioGR_000457
KBioGR_001580
KBioSS_000457
KBioSS_001325
L-Histamin base
L-Histamine
L-histamine
L000292
LS-75835
Lopac-H-7250
Lopac0_000595
MLS000069447
MolPort-001-785-597
MolPort-002-042-264
NCGC00015513-01
NCGC00015513-08
NCGC00093371-02
NCGC00093371-03
NCGC00093371-04
NCGC00093371-05
NINDS_000308
NSC 33792
NSC33792
SDCCGMLS-0066601.P001
SMP1_000151
SMR000059091
SPBio_000729
ST073926
STK346752
STOCK5S-55669
Spectrum2_000665
Spectrum3_000452
Spectrum4_000960
Spectrum5_000796
Spectrum_000845
Theramine
UNII-820484N8I3
WLN: T5M CNJ D2Z
ZERO/004089
[3H]histamine
b-Imidazolyl-4-ethylamine
beta-Aminoethylglyoxaline
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
beta-aminoethylglyoxaline
beta-aminoethylimidazole
beta-aminothethylglyoxaline
bmse000744
histamine
nchembio.87-comp54
nchembio714-comp1
9
Melatoninapproved, nutraceutical, vet_approvedPhase 4, Phase 2, Phase 326873-31-4896
Synonyms:
0E2B08C1-B325-45B1-8939-6F9081EFDFA4
4-ACETAMIDO-4'-ISOTHIO-CYANATOSTILBENE-2,2'-DISULFONIC ACID
5-22-12-00042 (Beilstein Handbook Reference)
5-Methoxy-N-acetyltryptamine
5-methoxy-N-acetyltryptamine
73-31-4
A4039/0172195
AB00053279
AC1L1A9Q
AC1Q4F1W
AC1Q4F1X
AKOS000276269
Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)- (9CI)
Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI)
Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI)
Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}
Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}
BAS 01281092
BIDD:ER0618
BPBio1_000590
BRD-K97530723-001-07-6
BRN 0205542
BSPBio_000536
BSPBio_003006
Bio-0635
C01598
CAS-73-31-4
CCRIS 3472
CHEBI:16796
CHEMBL45
CID896
ChemDiv2_003916
Circadin
D008550
D08170
DB01065
DB08189
DivK1c_000353
EINECS 200-797-7
EU-0100787
HMS1380B22
HMS1569K18
HMS1921E04
HMS2089F09
HMS501B15
HSCI1_000400
HSDB 7509
I05-0076
I10-0345
IDI1_000353
IDI1_002631
IN1244
KBio1_000353
KBio2_000665
KBio2_003233
KBio2_005801
KBio3_002226
KBioGR_000591
KBioSS_000665
L001261
LS-1623
Lopac-M-5250
Lopac0_000787
M 5250
M-1200
M-1250
M1105
M5250_SIGMA
ML1
MLS000859594
MLS001055382
MLS001240204
MT6
Mela-T
Melapure
Melatol
Melatonex
Melatonex, Melatonin
Melatonin
Melatonin (synth.) standard-grade
 
Melatonin (synth.) ultra-pure
Melatonina
Melatonina (TN)
Melatonine
Melovine
MolPort-000-737-883
N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)-Acetamide
N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide
N-Acetyl-5-methoxy-tryptamine
N-Acetyl-5-methoxy-tryptamine Melatonine
N-Acetyl-5-methoxytryptamine
N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]-Acetamide
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide
N-[2-(5-methoxyindol-3-yl)ethyl]acetamide
N-acetyl-5-methoxy-tryptamine
NCGC00015680-01
NCGC00015680-02
NCGC00015680-03
NCGC00015680-06
NCGC00015680-13
NCGC00090727-01
NCGC00090727-02
NCGC00090727-03
NCGC00090727-04
NCGC00090727-05
NCGC00090727-06
NCGC00090727-07
NCGC00090727-08
NCGC00090727-09
NCI60_004378
NINDS_000353
NMR/14327425
NSC 113928
NSC113928
NSC56423
Nature'S Harmony
Night Rest
Oprea1_104553
Oprea1_814234
PREVENTION 1 (MELATONIN) (PREVENTION 1)
PREVENTION 2 (MELATONIN)
PREVENTION 3 (MELATONIN)
PREVENTION 4 (MELATONIN)
PREVENTION 5 (MELATONIN)
Pineal Hormone
Posidorm
Prestwick0_000458
Prestwick1_000458
Prestwick2_000458
Prestwick3_000458
Prestwick_312
Regulin
Revital Melatonin
Rx Balance
S1204_Selleck
SDCCGMLS-0065812.P001
SDCCGMLS-0065812.P002
SMP2_000309
SMR000326666
SPBio_001527
SPBio_002475
SPECTRUM1500690
STK386880
Sleep Right
Spectrum2_001344
Spectrum3_001393
Spectrum4_000066
Spectrum5_001745
Spectrum_000185
TNP00300
UNII-JL5DK93RCL
Vivitas
WLN: T56 BMJ D2MV1 GO1
ZINC00057060
{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide
{N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide
10Cytochrome P-450 Enzyme InhibitorsPhase 43917
11Cytochrome P-450 CYP2D6 InhibitorsPhase 4727
12Dopamine AgentsPhase 43836
13Hydrocortisone 17-butyrate 21-propionatePhase 4667
14Antidepressive AgentsPhase 4, Phase 22736
15Hydrocortisone acetatePhase 4667
16HormonesPhase 414415
17Dopamine Uptake InhibitorsPhase 41331
18Cortisol succinatePhase 4667
19Cholinergic AntagonistsPhase 41706
20Serotonin Uptake InhibitorsPhase 41587
21Cholinergic AgentsPhase 4, Phase 3, Phase 1, Phase 23992
22Autonomic AgentsPhase 4, Phase 210150
23Antidepressive Agents, Second-GenerationPhase 41311
24Antiparkinson AgentsPhase 41574
25Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 118340
26Muscarinic AntagonistsPhase 41166
27Neurotransmitter Uptake InhibitorsPhase 43521
28Psychotropic DrugsPhase 4, Phase 26430
29
SerotoninPhase 4362750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
30Peripheral Nervous System AgentsPhase 4, Phase 223689
31ParasympatholyticsPhase 41085
32Serotonin AgentsPhase 43156
33AntioxidantsPhase 4, Phase 2, Phase 33050
34Adrenergic alpha-AntagonistsPhase 4, Phase 2739
35Adrenergic AntagonistsPhase 4, Phase 21573
36Protective AgentsPhase 4, Phase 3, Phase 27443
37Adrenergic AgentsPhase 4, Phase 25352
38Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Early Phase 113403
39Dopamine agonistsPhase 4632
40Gastrointestinal AgentsPhase 48402
41Dopamine AntagonistsPhase 41093
42Antipsychotic AgentsPhase 4, Phase 22401
43Tranquilizing AgentsPhase 44265
44AntiemeticsPhase 44022
45Serotonin AntagonistsPhase 41409
46
Histamine PhosphatePhase 4104951-74-165513
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
 
EINECS 200-118-4
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
47Pharmaceutical SolutionsPhase 4, Phase 28192
48Histamine H1 AntagonistsPhase 4791
49Histamine AntagonistsPhase 4961
50
IodinePhase 45707553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine

Interventional clinical trials:

(show top 50)    (show all 67)
idNameStatusNCT IDPhase
1Escitalopram and Sleep Architecture in Patients With Major Depressive DisorderUnknown statusNCT00442481Phase 4
2Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With DepressionUnknown statusNCT00106197Phase 4
3Study to Determine Whether Ramelteon Helps People With REM Sleep Behavior DisorderCompletedNCT01401413Phase 4
4Treating Disrupted Sleep in Individuals With Inflammatory Bowel DiseaseCompletedNCT02162862Phase 4
5An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar DepressionCompletedNCT00835107Phase 4
6An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed PatientsCompletedNCT00520507Phase 4
7Effect of Slow-release Melatonin (Circadin®) Therapy on Idiopathic RBD: a Pilot StudyRecruitingNCT02836743Phase 4
8Treatment of Sleep Disturbances in Trauma-affected RefugeesRecruitingNCT02761161Phase 4
9DaTSCAN Imaging in Aging and Neurodegenerative DiseaseEnrolling by invitationNCT01453127Phase 4
10Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's DiseaseEnrolling by invitationNCT02768077Phase 4
11Study of Rivastigmine to Treat Parkinsonian Apathy Without DementiaCompletedNCT00767091Phase 3
12Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated InsomniaCompletedNCT00856973Phase 3
13Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated InsomniaCompletedNCT00857220Phase 3
14Melatonin 3mg and 5mg Compared to Cognitive Behavioral Therapy for Insomnia (CBT-I) in the Treatment of InsomniaNot yet recruitingNCT02798367Phase 2, Phase 3
15Effect of Clonazepam on REM Sleep Behavior Disorder in Patients With ParkinsonismCompletedNCT02312908Phase 2
16The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With AutismCompletedNCT00695136Phase 1, Phase 2
17Rapid Antidepressant Effects of Yohimbine in Major DepressionCompletedNCT00078715Phase 2
18Pilot Study of Melatonin and EpilepsyCompletedNCT00965575Phase 2
19Study Evaluating Nelotanserin for Treatment of REM Sleep Behavior Disorder in Subjects With Dementia (DLB or PDD)RecruitingNCT02708186Phase 2
20A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's DiseaseRecruitingNCT02818777Phase 2
21Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderEnrolling by invitationNCT02871427Phase 2
22Efficacy and Safety of Melatonin PR and Clonazepam in Patients With REM Sleep Behavior Disorder in Parkinson DiseaseNot yet recruitingNCT02789592Phase 2
23A Trial of the Drug Donepezil for Sleep Enhancement and Behavioral Change in Children With AutismTerminatedNCT01887132Phase 2
24A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary InsomniaWithdrawnNCT00748592Phase 2
25A Trial to Investigate the Impact of Nocturnal Hypoglycaemia on Sleep in Subjects With Type 2 DiabetesCompletedNCT01780272Phase 1
26Understanding the Natural History of REM Sleep Behavior DisorderUnknown statusNCT01674998
27Acupuncture for the Sleep Disorder of Chronic Fatigue SyndromeUnknown statusNCT01534130
28Sleep Promotion in Critically Ill and Injured Patients Cared for in the Intensive Care UnitUnknown statusNCT01082016
29Brain Imaging in the Idiopathic REM Sleep Behavior Disorder (ALICE)CompletedNCT03072940
30MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.CompletedNCT01547481
31Cognitive Benefits of Treating Sleep Apnea in Parkinson's DiseaseCompletedNCT00492115
32Effects of Napping in Sleep-Restricted AdolescentsCompletedNCT02838095
33Dopamine Transporter Density Profiles in Patients With Periodic Limb MovementsCompletedNCT01365364
34Cognitive Behavioral Therapy for the Treatment of Depression-Related InsomniaCompletedNCT00255905
35Sleep Investigation in Respirator Treated ICU Patients: the Importance of Intensive EnvironmentCompletedNCT01681043
36Augmentation of Exposure Therapy for High Levels of Social Anxiety Using Post-exposure NapsCompletedNCT02325128
37Combined and Isolated Effects of Sleep Deprivation and Alcohol Intake on Exercise Performance in Humans.CompletedNCT02117193
38SLEEP AND OSA ON REPRODUCTIVE FUNCTION IN MENCompletedNCT01884454
39The Effect of the Mediterranean Diet on Obstructive Sleep Apnoea-Hypopnoea Syndrome: A Randomised TrialCompletedNCT01312558
40Exploration of the Reward System by Functional MRI in Parkinson's Disease Patients With and Without REM Sleep Behavior DisorderRecruitingNCT02824341
41Detecting Parkinson's Disease Through Speech AnalysisRecruitingNCT03133611
42Gait and REM Sleep Behavior DisorderRecruitingNCT02554331
43Prospective Neuroimaging Investigation of Idiopathic REM Sleep Behavior DisorderRecruitingNCT02984137
44Exploration of the Mechanism of Movement Improvement During RBD in Parkinson's Disease Using NIRSRecruitingNCT03060239
45RBD Longitudinal as Prognostic for PDRecruitingNCT00817726
46Natural History Study of SynucleinopathiesRecruitingNCT01799915
47Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson DiseaseRecruitingNCT02640339
48Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's DiseaseRecruitingNCT02305147
49Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine SurgeryRecruitingNCT02550626
50Sleep, Awake & Move - Part IIRecruitingNCT02710487

Search NIH Clinical Center for Rem Sleep Behavior Disorder


Cochrane evidence based reviews: rem sleep behavior disorder

Genetic Tests for Rem Sleep Behavior Disorder

About this section

Anatomical Context for Rem Sleep Behavior Disorder

About this section

MalaCards organs/tissues related to Rem Sleep Behavior Disorder:

36
Eye, Brain, Testes, Pons, Heart

Publications for Rem Sleep Behavior Disorder

About this section

Articles related to Rem Sleep Behavior Disorder:

(show top 50)    (show all 362)
idTitleAuthorsYear
1
Alterations of awake EEG in idiopathic REM sleep behavior disorder without cognitive impairment. (27894921)
2017
2
Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy. (27898200)
2016
3
Caring burden of REM sleep behavior disorder - spouses' health and marital relationship. (27810184)
2016
4
The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease. (27306265)
2016
5
Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies. (27060952)
2016
6
Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder. (27010070)
2016
7
Screening for REM sleep behavior disorder in the general population. (27697450)
2016
8
Depressed REM Sleep Behavior Disorder Patients Are Less Likely to Recall Enacted Dreams than Non-Depressed Ones. (27081385)
2016
9
Idiopathic REM sleep behavior disorder and neurodegenerative risk: To tell or not to tell to the patient? How to minimize the risk? (28082168)
2016
10
Seeking Good Alternatives to Clonazepam: Suggestions for Future Treatment Trials in REM Sleep Behavior Disorder. (27448419)
2016
11
National validation and proposed revision of REM sleep behavior disorder screening questionnaire (RBDSQ). (27671482)
2016
12
Brain pathway differences between Parkinson's disease patients with and without REM sleep behavior disorder. (27853964)
2016
13
Many faces of REM sleep behavior disorder: an editorial. (26750738)
2016
14
Detecting the cognitive prodrome of dementia with Lewy bodies: A prospective study of REM sleep behavior disorder. (27692054)
2016
15
Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. (27318706)
2016
16
Loss of REM sleep features across nighttime in REM sleep behavior disorder. (26847988)
2016
17
Abnormal baseline brain activity in Parkinson's disease with and without REM sleep behavior disorder: A resting-state functional MRI study. (27880010)
2016
18
Increased Motor Activity During REM Sleep Is Linked with Dopamine Function in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. (27070245)
2016
19
Brain imaging findings in idiopathic REM sleep behavior disorder (RBD) - A systematic review on potential biomarkers for neurodegeneration. (27542516)
2016
20
Periodic Limb Movements during Sleep Mimicking REM Sleep Behavior Disorder. (27923426)
2016
21
The role of the melanoma gene MC1R in Parkinson disease and REM sleep behavior disorder. (27131830)
2016
22
Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder. (26656284)
2016
23
Effects of Rotigotine on REM Sleep Behavior Disorder in Parkinson Disease. (27568909)
2016
24
Comparison between Automatic and Visual Scorings of REM Sleep without Atonia for the Diagnosis of REM Sleep Behavior Disorder in Parkinson Disease. (27923423)
2016
25
A case series of REM sleep behavior disorder in pure autonomic failure. (27757562)
2016
26
Risk Factor Profile in Parkinson's Disease Subtype with REM Sleep Behavior Disorder. (26889635)
2016
27
REM sleep behavior disorder and periodic leg movements during sleep in ALS. (27027974)
2016
28
Metabolic abnormality of pontine tegmentum in patients with REM sleep behavior disorder analyzed using magnetic resonance spectroscopy. (27448046)
2016
29
Absence of LRRK2 mutations in a cohort of patients with idiopathic REM sleep behavior disorder. (26747879)
2016
30
REM sleep behavior disorder was associated with Parkinson's disease: a community-based study. (27484952)
2016
31
Pareidolias in REM sleep behavior disorder: a possible predictive marker of Lewy body diseases? (27855735)
2016
32
Treatment of REM Sleep Behavior Disorder. (27752878)
2016
33
The combined effect of REM sleep behavior disorder and hyposmia on cognition and motor phenotype in Parkinson's disease. (27538667)
2016
34
Electrophysiological Evidence for Alternative Motor Networks in REM Sleep Behavior Disorder. (27852786)
2016
35
Cognitive study on Chinese patients with idiopathic REM sleep behavior disorder. (27288781)
2016
36
Prediction of later clinical course by a specific glucose metabolic pattern in non-demented patients with probable REM sleep behavior disorder admitted to a memory clinic: A case study. (26754469)
2016
37
Risk factors for probable REM sleep behavior disorder: A community-based study. (26819459)
2016
38
Efficacy of sodium oxybate on REM sleep behavior disorder in a patient with narcolepsy type 1. (27807183)
2016
39
Central Apneas and REM Sleep Behavior Disorder as an Initial Presentation of Multiple System Atrophy. (26518702)
2015
40
The Role of the Serotonergic System in REM Sleep Behavior Disorder. (25845692)
2015
41
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence. (25454845)
2015
42
Idiopathic REM Sleep Behavior Disorder: A Report on Two Cases with Contrasting Features. (26664088)
2015
43
Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression. (25568298)
2015
44
Parkinson disease with REM sleep behavior disorder: features, I+-synuclein, and inflammation. (25663225)
2015
45
Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder? (26410306)
2015
46
Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease. (27060938)
2015
47
REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. (26366513)
2015
48
Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression. (25929659)
2015
49
Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. (26085299)
2015
50
Differential diagnosis of sporadic adult-onset ataxia: The role of REM sleep behavior disorder. (25899546)
2015

Variations for Rem Sleep Behavior Disorder

About this section

Expression for genes affiliated with Rem Sleep Behavior Disorder

About this section
Search GEO for disease gene expression data for Rem Sleep Behavior Disorder.

Pathways for genes affiliated with Rem Sleep Behavior Disorder

About this section

GO Terms for genes affiliated with Rem Sleep Behavior Disorder

About this section

Cellular components related to Rem Sleep Behavior Disorder according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1inclusion bodyGO:001623410.4LRRK2, SNCA
2rough endoplasmic reticulumGO:000579110.2HCRT, SNCA
3axonGO:003042410.1LRRK2, SLC6A3, SNCA
4neuronal cell bodyGO:004302510.0LRRK2, SLC6A3, SNCA
5synaptic vesicle membraneGO:003067210.0LRRK2, SLC17A5
6lysosomeGO:00057649.9LRRK2, SLC17A5, SNCA
7postsynapseGO:00987949.8HCRT, LRRK2, SNCA
8terminal boutonGO:00431959.7LRRK2, SNCA
9synaptic vesicleGO:00080219.6HCRT, LRRK2, SNCA
10cell junctionGO:00300548.8ACHE, HCRT, LRRK2, SLC17A5, SNCA
11synapseGO:00452028.7ACHE, HCRT, LRRK2, SLC17A5, SNCA

Biological processes related to Rem Sleep Behavior Disorder according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1dopamine biosynthetic processGO:004241610.4SLC6A3, SNCA
2dopamine uptake involved in synaptic transmissionGO:005158310.4SLC6A3, SNCA
3negative regulation of neuron deathGO:190121510.3LRRK2, SNCA
4negative regulation of protein phosphorylationGO:000193310.3LRRK2, SNCA
5regulation of locomotionGO:004001210.2LRRK2, SNCA
6neurotransmitter biosynthetic processGO:004213610.2ACHE, SLC6A3
7regulation of neuron deathGO:190121410.2LRRK2, SNCA
8receptor internalizationGO:003162310.2ACHE, SNCA
9regulation of neurotransmitter secretionGO:00469289.9HCRT, SNCA
10response to cocaineGO:00422209.8SLC6A3, SNCA
11excitatory postsynaptic potentialGO:00600799.7HCRT, LRRK2, SNCA

Sources for Rem Sleep Behavior Disorder

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet